Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 4/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.43 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | NLRP3 | Q96P20 | 3/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30760739 | 1.00 | THRB (0.50) | THRBTP53ALDH1A1TDP1NR1I2 | |
| SCHEMBL19281448 | 1.00 | THRB (0.50) | THRBTP53ALDH1A1TDP1NR1I2 | |
| SCHEMBL2673039 | 0.88 | THRB (0.50) | THRBTP53ALDH1A1TDP1NR1I2 | |
| SCHEMBL9211321 | 0.87 | THRB (0.55) | THRBTP53ALDH1A1TDP1CYP3A4 | |
| SCHEMBL5093716 | 0.85 | TP53 (0.59) | THRBTP53ALDH1A1TDP1NR1I2 | |
| Metolachor SCHEMBL21385 | 0.82 | ALDH1A1 (0.59) | THRBTP53ALDH1A1TDP1NR1I2 | |
| Metolachor SCHEMBL338302 | 0.82 | ALDH1A1 (0.59) | THRBTP53ALDH1A1TDP1NR1I2 | |
| S-Metolachlor SCHEMBL118065 | 0.82 | ALDH1A1 (0.59) | THRBTP53ALDH1A1TDP1NR1I2 | |
| S-Metolachlor SCHEMBL31170483 | 0.82 | ALDH1A1 (0.59) | THRBTP53ALDH1A1TDP1NR1I2 | |
| Metolachor SCHEMBL18115413 | 0.82 | ALDH1A1 (0.59) | THRBTP53ALDH1A1TDP1NR1I2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220125048-A1 | HERBICIDAL COMPOSITIONS AND METHODS | SEPRO CORPORATION (US) | 2022-04-28 | — | — | US | disclosed |
| US-11026423-B2 | Herbicidal compositions and methods | SEPRO CORPORATION (US) | 2021-06-08 | — | — | US | disclosed |
| US-20200329708-A1 | HERBICIDE COMBINATION | UPL LIMITED EUROPE (GB) | 2020-10-22 | — | — | US | disclosed |
| EP-3207800-B1 | HERBICIDE COMBINATION | UPL EUROPE LTD (GB) | 2019-07-24 | — | — | EP | disclosed |
| US-9788543-B2 | Herbicidal compositions | SYNGENTA PARTICIPATIONS AG (CH) | 2017-10-17 | — | — | US | disclosed |
| WO-2017140650-A1 | HERBICIDE COMBINATION | UPL EUROPE LTD (GB) | 2017-08-24 | — | — | WO | disclosed |
| EP-3207800-A1 | HERBICIDE COMBINATION | UPL Europe Ltd (GB) | 2017-08-23 | — | — | EP | disclosed |
| US-20160286802-A1 | HERBICIDAL COMPOSITIONS AND METHODS | SEPRO CORPORATION | 2016-10-06 | — | — | US | disclosed |
| EP-2792243-B1 | Methods of controlling algae with thaxtomin and thaxtomin compositions | NOVOZYMES BIOLOGICALS INC (US) | 2016-07-06 | — | — | EP | disclosed |
| US-9204642-B2 | Herbicidal compositions and methods | SEPRO CORPORATION (US) | 2015-12-08 | — | — | US | disclosed |
| US-20150045216-A1 | HERBICIDAL COMPOSITIONS | SYNGENTA PARTICIPATIONS AG (CH) | 2015-02-12 | — | — | US | disclosed |
| US-20140352213-A1 | HERBICIDAL COMPOSITIONS AND METHODS | SEPRO CORPORATION | 2014-12-04 | — | — | US | disclosed |
| EP-2792243-A1 | Methods of controlling algae with thaxtomin and thaxtomin compositions | Novozymes Biologicals, Inc. (US) | 2014-10-22 | — | — | EP | disclosed |
| EP-2520167-B1 | Methods of controlling algae with thaxtomin and thaxtomin compositions | NOVOZYMES BIOLOGICALS INC (US) | 2014-05-21 | — | — | EP | disclosed |
| EP-2178374-B1 | METHODS OF CONTROLLING ALGAE WITH THAXTOMIN AND THAXTOMIN COMPOSITIONS | NOVOZYMES BIOLOGICALS INC (US) | 2013-01-02 | — | — | EP | disclosed |
| EP-2520167-A1 | Methods of controlling algae with thaxtomin and thaxtomin compositions | Novozymes Biologicals, Inc. (US) | 2012-11-07 | — | — | EP | disclosed |
| US-20080248956-A1 | Methods of Controlling Algae With Thaxtomin and Thaxtomin Compositions | NOVOZYMES BIOLOGICALS, INC. (US) | 2008-10-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080248956-A1 | Methods of Controlling Algae With Thaxtomin and Thaxtomin Compositions | TSNAX, TAGLN2, TKFC | THRB 1479/4885TP53 2493/4885ALDH1A1 4515/4885 |
| US-20150045216-A1 | HERBICIDAL COMPOSITIONS | DDT, DDC, ALDH7A1 | THRB 1163/4885TP53 134/4885ALDH1A1 49/4885 |
| US-20200329708-A1 | HERBICIDE COMBINATION | DDT, DPP4, DPP7 | THRB 505/4885TP53 2834/4885ALDH1A1 527/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.